Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1105 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Recordati agrees to acquire Frik Ilac

Frik Ilac has a core portfolio of original prescription products both in primary care and specialist areas and employs 350 personnel, of which around 260 are medical representatives.

GSK, Daiichi Sankyo to co-promote Rotarix in Japan

Clinical trials conducted in Japan and overseas have confirmed that Rotarix prevents severe rotavirus gastroenteritis and all rotavirus gastroenteritis. The Ministry of Health, Labour and Welfare (MHLW) has